AntalGenics — Seed · €808K

AntalGenics, a sensory neurobiology spin-off based at Miguel Hernández University's science park in Elche, raised €807,723 through the life-sciences equity crowdfunding platform Capital Cell to develop a neuro-drug that eliminates chronic itching in psoriasis. Inveready and private investors Antonio Ferrer and Antonio Parente also took part; no lead was stated.

Lead not disclosed RoundSeed Announced17 Feb 2022 CityElche SectorHealthtech & Bio · Biotech Source

Something wrong? Suggest a correction →

The company

Investors 4

Antonio Ferrer
Spain
Antonio Parente
SpainPrivate investor
Capital Cell
capitalcell.com
Spain
Inveready
www.inveready.com
Spain

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list